カテゴリー： 世界, IMARC

医薬品連続生産の世界市場2025-2033

【英語タイトル】Pharmaceutical Continuous Manufacturing Market Report by Therapeutics Type (Large Molecules, Small Molecules), Formulation (Solid Formulation, Liquid and Semi-solid Formulation), Application (Final Drug Product Manufacturing, API Manufacturing), End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Region 2025-2033

IMARCが出版した調査資料（IMA6339KL414）・商品コード：IMA6339KL414
・発行会社（調査会社）：IMARC
・発行日：2025年6月
・ページ数：約140
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2営業日）
・調査対象地域：グローバル
・産業分野：製薬
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,999 ⇒換算￥431,856見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,999 ⇒換算￥575,856見積依頼/購入/質問フォーム
Corporate License（閲覧人数無制限）USD4,999 ⇒換算￥719,856見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界の医薬品連続生産市場は2024年に15億米ドル規模に達し、IMARC Groupは2033年までに33億米ドルに拡大すると予測している。これは2025年から2033年にかけて年平均9.62％の成長率に相当し、健康意識の高まりや研究開発活動の増加が市場を後押ししている。規制当局も製品品質の向上、汚染リスクの低減、生産プロセスのリアルタイム監視といった利点から連続生産を積極的に支持しており、効率的な医薬品製造システムへの需要が高まっている。

市場環境では、北米が先進的な技術インフラと熟練人材、規制支援を背景に支配的な地位を占めている。一方で、システム導入コストの高さが課題とされるが、企業間の協力やリソースの共有が進むことでコスト負担が分散され、市場拡大の機会につながっている。競合環境では、Baker Perkins、Coperion、Eli Lilly、GEA Group、Glatt、Korsch、Novartis、Siemens、SK biotek、Thermo Fisher Scientific、Viatrisなどが主要プレーヤーとして挙げられる。

市場セグメント別では、治療分野では「スモールモレキュール（低分子医薬品）」が最大のシェアを占め、効率性と品質一貫性が評価されている。例えばVertex社は鎮痛薬Suzetrigineを連続生産で製造し、生産最適化と品質確保を実現している。製剤形態では「固形製剤」が主流で、錠剤やカプセルは連続生産に適しており、均一品質と大量生産を両立できる。XenoPharmaの事例では、錠剤生産により安定した品質とスケーラビリティが確保されている。

用途別では「最終製剤製造」が市場を牽引しており、無駄削減やコスト効率向上につながる。API製造でも導入は進んでいるが、完成品製造の効率性とスケールメリットが特に評価されている。エンドユーザー別では「製薬企業」が最大シェアを持ち、自社開発の効率化、製造プロセスの合理化、品質一貫性確保を目的に導入を拡大している。受託製造会社（CMO）やその他のユーザーも市場の一角を担っているが、依然として製薬企業が中心的存在である。

地域別では北米が優位を保ち、次いでアジア太平洋（中国、日本、インド、韓国など）が成長著しい市場となっている。欧州（ドイツ、フランス、英国、イタリアなど）も重要なシェアを占め、ラテンアメリカや中東・アフリカでも今後の拡大が期待される。総じて、医薬品連続生産市場は効率化と品質向上ニーズ、規制支援、R&D活動の拡大を背景に、今後10年で大きな成長が見込まれる分野である。

The global pharmaceutical continuous manufacturing market size reached USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 9.62% during 2025-2033. The rising health concerns and the increasing research and development activities are propelling the market growth.

Pharmaceutical Continuous Manufacturing Market Analysis:
• Major Market Drivers: Regulatory agencies are supportive of continuous manufacturing due to its potential to enhance product quality, reduce contamination risks, and provide real-time monitoring of the production process.
• Key Market Trends: The rising demand for effective medicine production systems is positively impacting the market growth.
• Competitive Landscape: Some of the prominent companies in the market include Baker Perkins, Coperion GmbH (Hillenbrand Inc.), Eli Lilly and Company, GEA Group Aktiengesellschaft, Glatt GmbH, Korsch AG, Novartis AG, Siemens, SK biotek, Thermo Fisher Scientific Inc., and Viatris Inc., among many others.
• Geographical Trends: North America exhibits a clear dominance in the market due to its advanced technological infrastructure. Apart from this, the region’s highly skilled workforce and strong regulatory support accelerate the market growth.
• Challenges and Opportunities: The high cost of systems is hindering the market. However, industry collaborations and shared resources help in distributing the cost and knowledge, which strengthens the market growth.

Global Pharmaceutical Continuous Manufacturing Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the pharmaceutical continuous manufacturing market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on therapeutics type, formulation, application, and end user.

Breakup by Therapeutics Type:
• Large Molecules
• Small Molecules

Small molecules dominate the pharmaceutical continuous manufacturing market
The report has provided a detailed breakup and analysis of the market based on the therapeutics type. This includes large molecules and small molecules. According to the report, small molecules represented the largest market segmentation.
Continuous manufacturing enhances efficiency and consistency in small-molecule drugs. Vertex Pharmaceuticals introduced Suzetrigine, a small molecule drug manufactured using continuous processes, optimizing production efficiency and ensuring consistent quality for pain management.

Breakup by Formulation:
• Solid Formulation
• Liquid and Semi-solid Formulation

Solid formulation currently holds most of the pharmaceutical continuous manufacturing market demand
The report has provided a detailed breakup and analysis of the market based on the formulation. This includes solid formulation and liquid and semi-solid formulation. According to the report, solid formulation represented the largest market segmentation.
Solid formulations, such as capsules and tablets, excel in continuous manufacturing due to improved consistency and efficiency. For example, XenoPharma’s tablet production ensures uniform quality and scalable output, which is acting as another significant growth-inducing factor.

Breakup by Application:
• Final Drug Product Manufacturing
• API Manufacturing

Final drug product manufacturing dominates the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes final drug product manufacturing and API manufacturing. According to the report, final drug product manufacturing represented the largest market segmentation.
Final drug product manufacturing in continuous processes ensures efficient production with consistent quality and scalability, thereby reducing waste and enhancing overall process control. It also results in cost savings. This is bolstering the pharmaceutical continuous manufacturing market revenue.

Breakup by End User:
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Others

Pharmaceutical companies hold most of the pharmaceutical continuous manufacturing market outlook
The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical companies, contract manufacturing organizations, and others. According to the report, pharmaceutical companies represented the largest market segmentation.
Pharmaceutical companies increasingly adopt continuous manufacturing to enhance efficiency, streamline production processes, and ensure consistent product quality. This is leading to faster and more cost-effective drug development.

Breakup by Region:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

❖ レポートの目次 ❖

​1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmaceutical Continuous Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapeutics Type
6.1 Large Molecules
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Small Molecules
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Formulation
7.1 Solid Formulation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Liquid and Semi-solid Formulation
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Final Drug Product Manufacturing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 API Manufacturing
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Contract Manufacturing Organizations
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Baker Perkins
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Coperion GmbH (Hillenbrand Inc.)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Eli Lilly and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 GEA Group Aktiengesellschaft
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Glatt GmbH
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Korsch AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Novartis AG
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Siemens
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 SK biotek
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Thermo Fisher Scientific Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Viatris Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials

List of Figures

Figure 1: Global: Pharmaceutical Continuous Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Therapeutics Type (in %), 2024
Figure 5: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Formulation (in %), 2024
Figure 6: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Application (in %), 2024
Figure 7: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by End User (in %), 2024
Figure 8: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Region (in %), 2024
Figure 9: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Pharmaceutical Continuous Manufacturing (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Pharmaceutical Continuous Manufacturing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: North America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: North America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: United States: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: United States: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Canada: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Canada: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: China: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: China: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Japan: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Japan: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: India: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: India: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: South Korea: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: South Korea: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Australia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Australia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Indonesia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Indonesia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Europe: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Europe: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Germany: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Germany: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: France: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: France: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: United Kingdom: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: United Kingdom: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Italy: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Italy: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Spain: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Spain: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Russia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Russia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Latin America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Latin America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Brazil: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Brazil: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Mexico: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Mexico: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Breakup by Country (in %), 2024
Figure 75: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Global: Pharmaceutical Continuous Manufacturing Industry: SWOT Analysis
Figure 77: Global: Pharmaceutical Continuous Manufacturing Industry: Value Chain Analysis
Figure 78: Global: Pharmaceutical Continuous Manufacturing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Pharmaceutical Continuous Manufacturing Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Therapeutics Type (in Million USD), 2025-2033
Table 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Formulation (in Million USD), 2025-2033
Table 4: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Pharmaceutical Continuous Manufacturing Market: Competitive Structure
Table 8: Global: Pharmaceutical Continuous Manufacturing Market: Key Players



★調査レポート[医薬品連続生産の世界市場2025-2033] (コード：IMA6339KL414)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品連続生産の世界市場2025-2033]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 医薬品ガラス包装の世界市場2025-2033
  • インドのトラック市場2025-2033
  • 医薬品連続生産の世界市場2025-2031
  • ウイスキーの世界市場2025-2033
  • 建設機械の世界市場2025-2033
  • 日本のデジタルヘルス市場2025-2033
  • 金属鍛造品の世界市場2025-2033
  • 血液浄化装置の世界市場2025-2033
  • インドのトラクター市場2025-2033
  • 光学センサーの世界市場2025-2033

    • ◆H&Iグローバルリサーチのお客様（例）◆